🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Franck Rahaghi

ORCID: 0000-0003-0803-4005

Also affiliated with United Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry”.

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

International Journal of COPD(2020)10.2147/copd.s263725

N/A

0DataRank · unranked

24 citations

Richard Monk, Viswanathan Ramakrishnan, Tatsiana Beiko, Charlie Strange, Franck Rahaghi

Riociguat for Sarcoidosis-Associated Pulmonary Hypertension

CHEST Journal(2021)10.1016/j.chest.2021.07.2162

N/A

0DataRank · unranked

47 citations

Oksana A. Shlobin, Rohit Gupta, Peter J. Engel, Jeffrey Stewart, Elyse E. Lower +4 more

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease

CHEST Journal(2022)10.1016/j.chest.2022.02.012

N/A

0DataRank · unranked

74 citations

Nicholas A. Kolaitis, Ayodeji Adegunsoye, João A. de Andrade, Kevin R. Flaherty, Lisa Lancaster +11 more